2006
DOI: 10.1016/j.vaccine.2006.05.115
|View full text |Cite
|
Sign up to set email alerts
|

Chapter 1: HPV in the etiology of human cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

17
890
2
89

Year Published

2007
2007
2018
2018

Publication Types

Select...
9
1

Relationship

1
9

Authors

Journals

citations
Cited by 1,088 publications
(998 citation statements)
references
References 31 publications
17
890
2
89
Order By: Relevance
“…m 5 number of subjects in the respective category; n 5 number of subjects with nonmissing data (serology, PCR, or both) at day 1 for HPV 6, 11, 16, and 18. 1 Positive (negative) by serology is defined as an anti-HPV cLIA titer (<) the serostatus cutoff of 20, 16, 20, or 24, respectively, for HPV 6, 11, 16, or 18.- 2 Positive by PCR to a given HPV type is defined as having a positive PCR result for the respective HPV type at day 1 on at least 1 required swab or (if obtained) biopsy sample. Negative by PCR to a given HPV type is defined as having negative PCR results for the respective HPV type at day 1 on all required swabs and (if obtained) biopsy samples.…”
Section: Resultsmentioning
confidence: 99%
“…m 5 number of subjects in the respective category; n 5 number of subjects with nonmissing data (serology, PCR, or both) at day 1 for HPV 6, 11, 16, and 18. 1 Positive (negative) by serology is defined as an anti-HPV cLIA titer (<) the serostatus cutoff of 20, 16, 20, or 24, respectively, for HPV 6, 11, 16, or 18.- 2 Positive by PCR to a given HPV type is defined as having a positive PCR result for the respective HPV type at day 1 on at least 1 required swab or (if obtained) biopsy sample. Negative by PCR to a given HPV type is defined as having negative PCR results for the respective HPV type at day 1 on all required swabs and (if obtained) biopsy samples.…”
Section: Resultsmentioning
confidence: 99%
“…The late genes (L1 and L2) and early genes (E6, E7, E1, E2, E4 and E5) that are expressed in more than 100 different HPV genotypes have been identified based on DNA sequence variations. They are classified according to various criteria such as their tissue tropism, potential of oncogenic and phylogenetic relationship using molecular biology techniques (Szostek et al, 2008).Human Papillomavirus (HPV) plays a very important role in cervical cancer and 99.7% of HPV DNA identified in invasive cervical carcinomas (Walboomers et al, 1999;Munoz et al, 2006). The prevalence of HPV infection varies substantially among countries and according to lifestyle, age, food and nutrition.…”
Section: Introductionmentioning
confidence: 99%
“…19 Routine provision of Pap testing has resulted in a significant drop in cervical cancer mortality over the past 50 years, and in the last 20 years, the putative cause of cervical cancer, the human papillomavirus (HPV), was discovered. 20 In June 2006, a vaccine has been licensed that is 100% efficacious against two strains of HPV, 16 and 18, that are found in 70% of cervical cancer cases. 21 The excitement over the release of the vaccine and continued emphasis and clarification on Pap testing recommendations have led to the development and dissemination of a plethora of publications including newspaper and magazine articles, health education brochures, and revised insurance and health system forms.…”
mentioning
confidence: 99%